HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corticosteroids in Stevens-Johnson Syndrome/toxic epidermal necrolysis: current evidence and implications for future research.

AbstractOBJECTIVE:
To review the evidence for the use of steroids in adults presenting with Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), or overlap.
DATA SOURCES:
EMBASE (1974 to April 2014), MEDLINE (1946 to April 2014), Cochrane Database of Systematic Reviews, and International Pharmaceutical Abstracts (1970 to January 2014) were searched using the terms: prednisone, methylprednisolone, dexamethasone, prednisolone, steroids, glucocorticoids, corticosteroids, Stevens-Johnson Syndrome, toxic epidermal necrolysis, and SJS/TEN overlap.
STUDY SELECTION AND DATA EXTRACTION:
English-language, full reports of experimental and observational studies were included. Bibliographies from pertinent publications were reviewed for additional references. Prespecified outcomes included survival, survival to discharge, hospitalization without intensive care, length of intensive care stay, duration of hospitalization, ophthalmological complications, infection rates, and adverse events.
DATA SYNTHESIS:
Six studies that used steroids for SJS, TEN, and/or overlap were included. All studies were retrospective cohort studies with no case-control or cross-sectional studies; 5 studies reported on steroid doses, and 2 studies reported time from disease onset to steroid use (2-4 days). Only 1 of 6 studies reported a statistically significant impact on mortality with steroids use (odds ratio = 0.4; 95% CI = 0.2-0.9). Adverse event rates were not reported in any of the studies.
CONCLUSIONS:
A review of the current evidence reveals a need for prospective, randomized controlled studies to provide more definitive conclusions on steroid use in patients with SJS, TEN, and/or overlap.
AuthorsErnest H Law, May Leung
JournalThe Annals of pharmacotherapy (Ann Pharmacother) Vol. 49 Issue 3 Pg. 335-42 (Mar 2015) ISSN: 1542-6270 [Electronic] United States
PMID25406459 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Copyright© The Author(s) 2014.
Chemical References
  • Adrenal Cortex Hormones
  • Cardiovascular Agents
  • Glucocorticoids
  • Dexamethasone
  • Prednisolone
  • Prednisone
Topics
  • Adrenal Cortex Hormones (therapeutic use)
  • Adult
  • Biomedical Research (trends)
  • Cardiovascular Agents (therapeutic use)
  • Cross-Sectional Studies
  • Dexamethasone (therapeutic use)
  • Glucocorticoids (therapeutic use)
  • Hospitalization (statistics & numerical data)
  • Humans
  • Prednisolone (therapeutic use)
  • Prednisone (therapeutic use)
  • Retrospective Studies
  • Stevens-Johnson Syndrome (drug therapy, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: